Biblio

Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Song S, Ma X. E2 enzyme Bruce negatively regulates Hippo signaling through POSH-mediated expanded degradation. Cell Death Dis. 2023;14(9):602.
Li X, Gao F, Wang X, Liang Q, Bai A, Liu Z, Chen X, Li E, Chen S, Lu C, et al. E2A ablation enhances proportion of nodal-like cardiomyocytes in cardiac-specific differentiation of human embryonic stem cells. EBioMedicine. 2021;71:103575.
Xie Q, Peng S, Tao L, Ruan H, Yang Y, Li T-M, Adams U, Meng S, Bi X, Dong M-Q, et al. E2F Transcription Factor 1 Regulates Cellular and Organismal Senescence by Inhibiting Forkhead Box O Transcription Factors. J Biol Chem. 2014.
Bertonnier-Brouty L, Andersson J, Kaprio T, Hagström J, Bsharat S, Asplund O, Hatem G, Haglund C, Seppänen H, Prasad RB, et al. E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma. Cancer Med. 2024;13(9):e7187.
Shirakawa J, Togashi Y, Basile G, Okuyama T, Inoue R, Fernandez M, Kyohara M, De Jesus DF, Goto N, Zhang W, et al. E2F1 transcription factor mediates a link between fat and islets to promote β cell proliferation in response to acute insulin resistance. Cell Rep. 2022;41(1):111436.
Jiang X, You H, Niu Y, Ding Y, Chen Z, Wang H, Xu Y, Zhou P, Wei L, Deng D, et al. E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability. Cancer Lett. 2024:216875.
Cheng FHC, Lin H-Y, Hwang T-W, Chen Y-C, Huang R-L, Bin Chang C-, Yang W, Lin R-I, Lin C-W, Chen GCW, et al. E2F6 Functions as a Competing Endogenous RNA, and Transcriptional Repressor, to Promote Ovarian Cancer Stemness. Cancer Sci. 2018.
Wu Y, Gu S, Cobb JM, Dunn GH, Muth TA, Simchick CJ, Li B, Zhang W, Hua X. E2-loaded Microcapsules and BMSCs with Injectable Scaffolds for Endometrial Regeneration Application. Tissue Eng Part A. 2023.
Tang SChuan, Lion Q, Peulen O, Chariot P, Lavergne A, Mayer A, Fuster PAllepuz, Close P, Klein S, Florin A, et al. The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer. Oncogene. 2021.
Pham T, Najy AJ, Kim H-RC. E3 ligase HUWE1 promotes PDGF D-mediated osteoblastic differentiation of mesenchymal stem cells by effecting polyubiquitination of β-PDGFR. J Biol Chem. 2022:101981.
Li T, Giagtzoglou N, Eberl D, Nagarkar-Jaiswal S, Cai T, Godt D, Groves AK, Bellen HJ. The E3 ligase Ubr3 regulates Usher syndrome and MYH9 disorder proteins in the auditory organs of Drosophila and mammals. Elife. 2016;5.
Illingworth RS, Moffat M, Mann AR, Read D, Hunter CJ, Pradeepa MM, Adams IR, Bickmore WA. The E3 ubiquitin ligase activity of RING1B is not essential for early mouse development. Genes Dev. 2015;29(18):1897-902.
Zhu Y, Li Y, Fei F, Wang Z, Wang W, Cao A, Liu Y, Han S, Xing L, Wang H, et al. An E3 ubiquitin ligase gene CMPG1-V from Haynaldia villosa L. contributes to the powdery mildew resistance in common wheat. Plant J. 2015.
Zhan Q, Wang J, Zhang H, Zhang L. E3 ubiquitin ligase on the biological properties of hematopoietic stem cell. J Mol Med (Berl). 2023.
Vengayil V, Rashida Z, Laxman S. The E3 ubiquitin ligase Pib1 regulates effective gluconeogenic shutdown upon glucose availability. J Biol Chem. 2019.
Davidson JM, Wu SSL, Rayner SL, Cheng F, Duncan K, Russo C, Newbery M, Ding K, Scherer NM, Balez R, et al. The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis. Mol Neurobiol. 2023.
Saez I, Gerbracht J, Koyuncu S, Lee HJu, Horn M, Kroef V, Denzel M, Dieterich C, Gehring N, Vilchez D. The E3 ubiquitin ligase UBR5 interacts with the H/ACA ribonucleoprotein complex and regulates ribosomal RNA biogenesis in embryonic stem cells. FEBS Lett. 2019.
Lambert N, Moïse M, Nguyen L. E3 Ubiquitin ligases and cerebral cortex development in health and disease. Dev Neurobiol. 2022.
Zou Q, Liu M, Liu K, Zhang Y, North BJ, Wang B. E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities. Cell Oncol (Dordr). 2023.
Grote D, Moison C, Duhamel S, Chagraoui J, Girard S, Yang J, Mayotte N, Coulombe Y, Masson J-Y, Brown GW, et al. E4F1 Is a Master Regulator of CHK1-Mediated Functions. Cell Rep. 2015.
Huang T-T, Chen C-M, Lin S-S, Lan Y-W, Cheng H-C, Choo K-B, Wang C-C, Huang T-H, Chong K-Y. E7050 Suppresses the Growth of Multidrug-Resistant Human Uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways. Int J Mol Sci. 2023;24(11).
Higuchi Y, Nguyen C, Chimge N-O, Ouyang C, Teo J-L, Kahn M. E7386 is not a Specific CBP/β-Catenin Antagonist. Curr Mol Pharmacol. 2023.
Hu Z, Rong X, Liu X. E7-Conjugated Bio-Inspired Microspheres as a Biological Barrier for Guided Tissue Regeneration. ACS Appl Mater Interfaces. 2023.
Liu Q-N, Trudeau MC. Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. PLoS One. 2015;10(4):e0123951.
Huang X, He Y, Dubuc AM, Hashizume R, Zhang W, Reimand J, Yang H, Wang TA, Stehbens SJ, Younger S, et al. EAG2 potassium channel with evolutionarily conserved function as a brain tumor target. Nat Neurosci. 2015.

Pages